10462993

Macio?ek-Blewniewska G

1999

[The evaluation of blood flow in uterine arteries in girls with polycystic ovary syndrome by transvaginal color Doppler ultrasonography].

10464001

Fridstr?m M

1999

Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia?

10468913

Pasquali R

1999

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.

10468971

Conway GS

1999

Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome.

10468975

Witchel SF

1999

Ovarian responses to hCG stimulation: insulin resistance/hyperinsulinaemia vs. insulin deficiency.

10468995

Unl?hizarci K

1999

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.

10468997

Ramanujam LN

1999

Association of molecular variants of luteinizing hormone with menstrual disorders.

10469683

Marsden PJ

1999

Adipocyte insulin action following ovulation in polycystic ovarian syndrome.

10469684

van Hooff MH

1999

Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents.

10469686

Teissier MP

1999

Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.

10472855

Douchi T

1999

Serum androgen levels and muscle mass in women with polycystic ovary syndrome.

10474119

Collet C

1999

Luteinizing hormone measurement in polycystic ovary syndrome: a practical approach.

10476555

Hagan P

1998

Diagnosing and treating polycystic ovary syndrome.

10476568

de Berker D

1999

The diagnosis and treatment of hirsutism.

10487660

Thierry van Dessel HJ

1999

Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.

10487672

Book CB

1999

Selective insulin resistance in the polycystic ovary syndrome.

10491635

Spaczynski RZ

1999

Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells.

10495567

Belaisch J

1999

[Spaniomenorrhea: a tentacular symptom].

10497917

Opsomer G

1999

Insulin resistance: the link between metabolic disorders and cystic ovarian disease in high yielding dairy cows?

10501353

Balen A

1999

Pathogenesis of polycystic ovary syndrome--the enigma unravels?

10503163

Szukiewicz D

1998

Polycystic ovary syndrome--searching for an animal model.

10504788

Forsbach G

1999

[Sublingual thyroid gland associated with polycystic ovaries].

10509302

Arthur LS

1999

Hyperinsulinemia in polycystic ovary disease.

10511782

Weerakiet S

1999

Efficacy of laparoscopic ovulation induction in polycystic ovary syndrome.

10519615

Paoletti AM

1999

Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.

10519616

Amato G

1999

Lack of insulin-like growth factor binding protein-3 variation after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization.

10521101

Chian RC

1999

Pregnancies resulting from in vitro matured oocytes retrieved from patients with polycystic ovary syndrome after priming with human chorionic gonadotropin.

10526249

Falsetti L

1999

Comparison of finasteride versus flutamide in the treatment of hirsutism.

10528931

Edwards HE

1999

Limbic seizures alter reproductive function in the female rat.

10536427

Prattichizzo FA

1999

[Problems of nosologic classification of polycystic ovary syndrome and metabolic syndrome X].

10545743

Turhan NO

1999

The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea.

10548604

Mitwally MF

1999

High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome.

10548605

Kaltsas T

1999

Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome.

10548608

Kousta E

1999

The prevalence of polycystic ovaries in women with infertility.

10549191

Carmina E

1999

Polycystic ovarian syndrome--an update on diagnostic evaluation.

10550878

Battaglia C

1999

Polycystic ovary syndrome: it is always bilateral?

10554748

Farah L

1999

Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group.

10561001

Carmina E

1999

Evidence that insulin and androgens may participate in the regulation of serum leptin levels in women.

10566641

Diamanti-Kandarakis E

1999

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

10566685

Lemieux S

1999

Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels.

10576524

Pugeat M

1999

Insulin resistance, polycystic ovary syndrome and metformin.

10577135

Chian RC

1999

Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome.

10579351

Couse JF

1999

Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse.

10582786

Homburg R

1999

Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements.

10588520

Ahmed S

1999

INS VNTR allelic variation and dynamic insulin secretion in healthy adult non-diabetic Caucasian subjects.

10592506

Kalafatis P

1999

Bilateral giant adrenal myelolipoma and polycystic ovarian disease.

10593368

la Marca A

1999

Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome.

10593369

Legro RS

1999

Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors.

10598343

Gandar R

1999

[Diagnosis and treatment of polycystic ovary syndrome].

10599552

Baranowska B

1999

Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.

10599730

Ropelato MG

1999

A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome.

10599746

Morgan JF

1999

Polycystic ovary syndrome, gestational diabetes, and bulimia nervosa.

10599993

Glueck CJ

1999

Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.

10601077

Ciotta L

1999

Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.

10601079

Pirwany IR

1999

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

10601080

Buckler HM

1999

Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).

10601598

Niwa K

2000

A case-control study of uterine endometrial cancer of pre- and post-menopausal women.

10605667

Maliqueo M

1999

[Relationship between leptin and insulin sensitivity in patients with polycystic ovary syndrome].

10611179

Egbase PE

2000

Severe OHSS: how many cases are preventable?

10611182

la Marca A

2000

Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.

10611183

Elting MW

2000

Women with polycystic ovary syndrome gain regular menstrual cycles when ageing.

10611194

Murray RD

2000

Clinical presentation of PCOS following development of an insulinoma: case report.

10611196

Philips Z

2000

Evaluation of the relative cost-effectiveness of treatments for infertility in the UK.

10611207

Chian RC

2000

Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.

10615316

Wilson JD

1999

HIV protease inhibitors, the lipodystrophy syndrome and polycystic ovary syndrome--is there a link?

10615913

Kelly C

2000

Polycystic ovaries.

10615960

Huxtable SJ

2000

Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles.

10617252

Panidis DK

1999

Hyperinsulinemia does not influence androgens/estrogens ratio in patients with polycystic ovarian syndrome.

10619984

Michelmore KF

1999

Polycystic ovaries and associated clinical and biochemical features in young women.

10624830

Adamopoulos DA

2000

Sex steroids in cervical mucus of spontaneous or induced ovulatory cycles.

10626547

Miller WL

1999

The molecular basis of premature adrenarche: an hypothesis.

10626548

Dimartino-Nardi J

1999

Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls.

10626549

Ib??ez L

1999

Endocrinology and metabolism after premature pubarche in girls.

10627765

Balen A

1998

Endocrine methods of ovulation induction.

10627766

Tulandi T

1998

Surgical management of polycystic ovarian syndrome.

10627767

Homburg R

1998

Adverse effects of luteinizing hormone on fertility: fact or fantasy.

10627768

Jacobs HS

1998

Complications of ovarian stimulation.

10627769

Goshen R

1998

Epithelial ovarian cancer, infertility and induction of ovulation: possible pathogenesis and updated concepts.

10627770

Buckett WM

1998

Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome.

10627771

Lubin V

1998

The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease.

10632431

Mather KJ

2000

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity.

10634370

Moghetti P

2000

Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.

10634377

Moghetti P

2000

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

10641516

Callies F

1999

[A hairy case].

10645855

Rajkhowa M

2000

Polycystic ovary syndrome: a risk factor for cardiovascular disease?

10646216

Kirchengast S

1999

Body composition characteristics, sex hormone levels and circadian gonadotropin fluctuations in infertile young women.

10646815

Fedorcs?k P

2000

Obesity is a risk factor for early pregnancy loss after IVF or ICSI.

10647777

Lackey BR

1999

The insulin-like growth factor (IGF) system and gonadotropin regulation: actions and interactions.

10649185

Abulafia O

2000

Angiogenesis of the ovary.

10651756

Walker BR

2000

Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome.

10651757

Conn JJ

2000

The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

10665587

Gazvani MR

2000

Polycystic ovarian disease: a misleading label?

10668160

Petrone A

1999

Usefulness of a 12-month treatment with finasteride in idiophathic and polycystic ovary syndrome-associated hirsutism.

10671954

Diamanti-Kandarakis E

2000

Metformin and polycystic ovary syndrome.

10671955

De Leo V

2000

Metformin and ovarian steroidogenesis in PCOS women.

10671956

Kelestimur F

2000

Metformin and polycystic ovary syndrome

10682427

Li L

1998

[Pathological and immunohistochemical study on estrogen and progesterone receptors in endometrium of polycystic ovarian syndrome].

10682439

Wang A

1998

[Effects of human chorionic gonadotropine and insulin on androgen production by cultured thecal cells from patients with polycystic ovary syndrome].

10682453

Wu X

1998

[Lipoprotein lipids in polycystic ovarian syndrome: independent associations with androgen excess and insulin resistance].

10682483

Wu X

1998

[Functional states of pituitary-ovary, adrenal and thyroid axes in women with polycystic ovarian syndrome].